title: Interaction between methotrexate and ciprofloxacin.
abstract: High-dose methotrexate is used in malignant hemopathies and solid tumors in children. Methotrexate serum concentrations must be monitored because of the possible toxicity of drug elimination delay. Several drugs (e.g., penicillin, probenecid) can alter the elimination of methotrexate. The authors report two cases of delayed elimination of methotrexate in patients receiving ciprofloxacin, with severe toxicity.
authors.affiliation: Unite d'Onco-Hematologie Pediatrique, Hopital Jeanne de Flandre, Lille, France. jhdalle@wanadoo.fr
authors.forename: Jean-Hugues
authors.initials: JH
authors.lastname: Dalle
authors.forename: Anne
authors.initials: A
authors.lastname: Auvrignon
authors.forename: Gilles
authors.initials: G
authors.lastname: Vassal
authors.forename: Guy
authors.initials: G
authors.lastname: Leverger
mesh_terms: D000293:Adolescent; D000890:Anti-Infective Agents / Q000009:adverse effects*; D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects* / Q000493:pharmacokinetics; D001859:Bone Neoplasms / Q000188:drug therapy; D002648:Child; D002675:Child, Preschool; D002939:Ciprofloxacin / Q000009:adverse effects* / Q000493:pharmacokinetics; D004347:Drug Interactions; D005260:Female; D006801:Humans; D008297:Male; D008727:Methotrexate / Q000009:adverse effects* / Q000097:blood / Q000493:pharmacokinetics; D009447:Neuroblastoma / Q000188:drug therapy; D012516:Osteosarcoma / Q000188:drug therapy
chemical_list: D000890:Anti-Infective Agents; D000964:Antimetabolites, Antineoplastic; D002939:Ciprofloxacin; D008727:Methotrexate